GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $250,000 | +88.0% | 1,152 | 0.0% | 0.01% | +30.0% |
Q4 2020 | $133,000 | +44.6% | 1,152 | +22.3% | 0.01% | +66.7% |
Q3 2020 | $92,000 | -14.8% | 942 | +6.9% | 0.01% | -25.0% |
Q2 2020 | $108,000 | +40.3% | 881 | 0.0% | 0.01% | +14.3% |
Q1 2020 | $77,000 | -25.2% | 881 | -10.2% | 0.01% | -12.5% |
Q4 2019 | $103,000 | +2.0% | 981 | +12.0% | 0.01% | -11.1% |
Q3 2019 | $101,000 | -33.1% | 876 | 0.0% | 0.01% | -25.0% |
Q2 2019 | $151,000 | +16.2% | 876 | +13.5% | 0.01% | +9.1% |
Q1 2019 | $130,000 | +1200.0% | 772 | -22.8% | 0.01% | +1000.0% |
Q4 2018 | $10,000 | -92.5% | 1,000 | +30.4% | 0.00% | -90.9% |
Q3 2018 | $133,000 | +54.7% | 767 | -5.8% | 0.01% | +57.1% |
Q2 2018 | $86,000 | 0.0% | 814 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $86,000 | -21.8% | 814 | -2.4% | 0.01% | -30.0% |
Q4 2017 | $110,000 | -23.6% | 834 | -41.3% | 0.01% | +11.1% |
Q3 2017 | $144,000 | +0.7% | 1,420 | 0.0% | 0.01% | -10.0% |
Q2 2017 | $143,000 | – | 1,420 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |